Amedisys (AMED) Tops Q1 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Amedisys Reports First Quarter 2021 Financial Results Updates 2021 Guidance
April 28, 2021 4:05 PM EDTBATON ROUGE, La., April 28, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2021.
Three-Month Periods Ended March 31, 2021 and 2020
Net service revenue increased $45.4Â million to $537.1Â million compared to $491.7Â million in 2020.Net income attributable to Amedisys, Inc. of $49.9Â million compared to $31.8Â million in 2020.Net income attributable to Amedisys, Inc. per diluted share of $1.50 compared to $0.96 in 2020.Adjusted Quarterly Results*
Adjusted EBITDA of $78.6Â million compared to $53.3Â million in 2020.Adjusted net income attributable to Amedisys, Inc. of $51.1Â million compared to... More